TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

Detailed price information for Netease Inc ADR (NTES-Q) from The Globe and Mail including charting and trades.

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Thermo Fisher Scientific Inc. closed 8.73% below its 52-week high of $627.88, which the company reached on September 10th.

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership for Lyndra's long-acting oral therapies ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...